Temporary Fatigue A small percentage of users report experiencing mild fatigue or lightheadedness, in the first few days of use
New Drug Therapy Approvals 2022
Doctronic.ai can help patients understand what these diagnostic tests involve before their appointments
Medical Weight Management Programs Our physician-guided weight loss program utilizes GLP-1 receptor agonist therapy to support sustainable weight loss by regulating appetite and improving metabolic function
AOD 9604 Drug Application for Bone Health AOD 9604 Capsule (Anti Obesity Drug 9604) is an artificially synthesized 16 amino acid peptide derived from the active fragment of human growth hormone (hGH) at positions 177-191 and structurally optimized
formulated with a scientifically selected blend of L-Carnitine, Co-Enzyme Q10, Astaxanthin (10%), Zinc Sulphate, Lycopene (6%), L-Arginine, Vitamins, and Minerals